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Abstract
Introduction: Patients who are transgender have unique population-specific needs and risk factors.
Nationwide surveys of health profession school administrators indicate a gap in coverage of lesbian, gay,
bisexual, and transgender health content in their curricula. To address this gap, a pharmacist-developed
transgender–health care focused seminar was presented to medical professionals, trainees, and students
accompanied by a novel education assessment scale.
Methods: The seminar was presented by a psychiatric pharmacy resident to health care professionals and
trainees in various settings. Subjects covered during the seminar included terminology, diagnostic criteria
and prevalence of gender dysphoria, nonhormonal treatment, gender-affirming hormone therapy, and other
considerations. The Trans* Health Education Evaluation Scale (THEES) was developed to assess participants’
self-perceived proficiency regarding care of patients who are transgender immediately before and after
attending a seminar. Total scale scores were compared preseminar and postseminar using a repeated-
measures t-test, and sign tests with Bonferroni correction were used for individual scale items. Psychometric
properties of this scale were examined.
Results: Five seminars were given, and a total of 100 scales were completed by health care–associated
workers and students. The majority of participants were in the pharmacy or medical professions. Attending
1 seminar significantly improved THEES total and individual item scores (P , .001). Additionally, 90% of
participants felt the seminar was directly applicable to their practice, and 84% felt more confident in
providing care to patients who are transgender.
Discussion: A single, pharmacist-led, trans health–focused education session significantly improved the
confidence level and self-perceived proficiency of health care–associated personnel as measured by THEES.
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Introduction
According to the national US Transgender Survey
completed in 2015, a third of the 27 715 respondents
reported a negative encounter with a health care provider,
including verbal harassment or refusal of treatment based
on their gender identity, and nearly a quarter of
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respondents avoided accessing health care for fear of
mistreatment.1 Literature2,3 consistently indicates that a
significant barrier to care for gender-diverse individuals is
a lack of access to health care providers who are
knowledgeable in gender-diverse care. Although certainly
a multifaceted issue, suboptimal medical care on a
national scale is likely a significant contributor to the
transgender population having a higher burden of health
inequalities, including significantly higher HIV infection
rates particularly in transgender women, greater incidence
of mental illness, and a rate of suicide attempts that is
nearly 9 times higher compared to the general US
population.1,2,4
Deficits in coverage of transgender content in health
profession education systems has received increasing
amounts of attention in recent years with multiple studies
examining gender-diverse content in medical and phar-
macy schools as well as interventions to improve trainees’
competency and awareness.5-10 In a 2011-2012 survey of
pharmacy schools in which 28 out of 125 responded, more
than half of respondents reported no coverage of LGBT
content in their curricula.7 More recently, a survey of
pharmacy schools was completed specifically addressing
transgender-related care in their curricula. Sixty-six
schools responded, and 41.2% of schools indicated that
transgender-related education is in their required curric-
ula.8 Incorporation of LGBT content into a first-year
pharmacy student course improved student self-aware-
ness and student capability in showing respect to trans-
gender people.7 Similarly, a 2009-2010 report of medical
schools indicated that coverage of LGBT content was fair
at 44% of responding medical schools, very poor or poor at
26% of schools, and very good or good at 24% of schools.9
Following the publication of those survey results, the
Association of American Medical Colleges published
guidance for including education regarding gender-diverse
and LGBT individuals. As a result, many medical schools
provide a median exposure of 5 hours of LGBT-related
content in their curricula.7 However, transgender health
should be recognized as a separate clinical skill set with
appropriate emphasis thereof.6
Recent efforts have begun to improve professional
education standards with regard to transgender health,
but many current clinicians and health care workers were
likely trained prior to ongoing improvements, and current
trainees may not yet benefit from improved curricula. To
address this gap in education, a pharmacist-developed,
transgender care–focused seminar was presented to
various health care–associated workers and students with
an accompanying assessment scale to provide data on
participants’ self-perceived proficiency before and after
education.
Methods
A novel, evidence-based, guideline-driven presentation was
developed centering around overall medical care for
patients who are transgender. Sources for the presentation
included, but were not limited to, World Professional
Association for Transgender Health Standards of Care
(2011), Endocrine Society Guidelines (2017), Center of
Excellence for Transgender Health Guidelines (2016), and
other reviews and primary literature.11-13 Content was
largely consistent with recommendations made by Dubin et
al.6 The presentation included discussion of terminology,
diagnosis and prevalence of gender dysphoria per the DSM-
5, nonhormonal treatment (eg, surgery, mental health
treatment for common comorbidities), gender-affirming
pharmacotherapy, and other primary care–related consid-
erations (eg, organ-specific cancer screenings, HIV pre-
exposure prophylaxis, renal dosing of medications, cardio-
vascular disease risk, bone health, family planning). The
presentation was created using Microsoft PowerPoint and
was intended to be delivered as a live, interactive session
given over a 45-minute duration with additional time for
questions and answers (Q&A) to audiences consisting of
various health care–associated workers and students.
Participation in sessions was voluntary, and opportunities
to provide the seminar were sought in accordance with the
pharmacy resident’s availability.
Alongside the presentation, the Trans* Health Education
Evaluation Scale (THEES) was developed to assess the
effectiveness of an education session with respect to
participants’ self-perceived proficiency and confidence in
providing care to gender-diverse patients. Items in the
scale were chosen to assess effectiveness of the main
topics in the developed education session. It was not
pretested prior to use alongside the seminars. The scale
was administered via paper hardcopy, printed front and
back with prescales and postscales, immediately before
and again after an education session. To maintain
anonymity, participants were instructed not write any
identifying information on the scale aside from occupa-
tion/position. The scale is composed of 8 items pertaining
to each main topic and is pictured in Table 1.
Two additional questions were added to the posteduca-
tion survey to assess participant confidence level and
direct clinical applicability:
1. This discussion has increased my confidence level for
providing care to transgender individuals.
2. I learned something from this discussion that I can
directly apply to my clinical setting.
Each item on the pre-education and posteducation THEES
is marked with one of the following responses: strongly
agree, agree, neither agree nor disagree, disagree, or
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strongly disagree. For the purposes of statistical evalua-
tion, responses were assigned a number 1 through 5 (a
Likert scale) with greater numbers indicating a greater
level of understanding.
The primary endpoints of this study were (1) the difference
in each item before and after education for all participants
and (2) the difference in the sum of all items before and after
education for all participants. Change in THEES total scores
from prepresentation to postpresentation was analyzed
using a repeated-measures t test with critical alpha being set
at P , .05. Similarly, differences for the individual scale
items before and after were analyzed using sign tests with a
critical value set at 0.00625 using a Bonferroni correction for
each of the 8 scale items to keep the experiment-wide
critical alpha at P , .05 or better. A principal component
analysis with Cattell scree plot suggested a 1-factor solution
was appropriate, and Cronbach a was used to assess the
internal consistency of the instrument. Secondary endpoints
to be assessed using descriptive statistics included partici-
pants’ reported confidence level after education and
perceived clinical applicability.
This research was approved by the institutional review
board at the Providence Veterans Affairs Medical Center.
This material is the result of work supported with resources
and the use of facilities at the Providence Veterans Affairs
Medical Center in Providence, Rhode Island.
Results
A total of 5 education sessions were given by the same
pharmacy resident in various settings between May and
September 2018. One hundred completed THEES were
obtained from unique participants. The reported occupa-
tions of participants are reported in Table 2. Two sessions
were delivered to medical residents and students during
their noon conference. One session was delivered to the
multidisciplinary women’s health primary care team. One
session was delivered to clinical pharmacists, residents,
and students during a pharmacy clinical meeting. The 4
preceding sessions were delivered over 45 minutes with
Q&A afterward. The final session was delivered to large
group (n¼ 52) of pharmacists and pharmacy technicians
for continuing education credit for a duration of 30
minutes with Q&A included. The content for this final
session was abbreviated to focus on medication therapy








Q1. I am able to utilize proper and sensitive terminology when
referring directly to and about medical care of transgender
individuals.
Q2. I am comfortable distinguishing between the terms gender
identity, gender expression, biological sex, and sexual attraction.
Q3. The goals of hormonal and non-hormonal therapies for gender
dysphoria are clear to me.
Q4. I am familiar with the medication regimen of cross-sex hormone
therapy for transgender individuals.
Q5. I feel adequately trained to provide medical care to transgender
individuals.
Q6. I am familiar with population-specific medical considerations for
transgender individuals.
Q7. I am aware of population-specific risks regarding medical care of
transgender individuals.
Q8. I am aware of the resources and literature that are available for
information on providing medical care to transgender
individuals.
TABLE 2: Occupations of scale responders










Licensed practical nurse 1
Social worker 2
Medical support assistant 3
Unknown 4
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but included information on each item included in the
THEES. A majority of participants (n¼66) were related to
the pharmacy profession (eg, pharmacist, pharmacy
technician, pharmacy resident, pharmacy student). The
next most populous group were participants in the
medical profession (eg, medical doctor, medical resident,
medical student).
THEES total scores as well as those for each individual scale
item were significantly improved (P , .001) after education.
The summed results of all THEES obtained from participants
are shown in the Figure. Before an education session,
participants scored items 1 and 2 the highest with mean
scores of 3.67 and 3.6, respectively. Items 3 through 8 on the
THEES were associated with individual mean scores
between 2.4 and 2.83 immediately prior to an education
session with improvement to mean scores 3.6 (range: 3.6
to 4.25) and at least 1 full point in magnitude of
improvement for each mean score. The greatest magnitude
of improvement in mean score (þ1.69) was seen in item 4, I
am familiar with the medication regimen of cross-sex hormone
therapy for transgender individuals. The THEES had both
good face validity as well as internal consistency with
Cronbach a for the THEES calculated as .885.
A vast majority of participants felt that the seminar was
directly applicable to their clinical setting with 90%
responding with agree or strongly agree. In the same
manner, 84% of participants felt an increase in confidence
after participation in a seminar, responding with agree or
strongly agree.
Discussion
Results collected from 5 interdisciplinary education
sessions indicate that a pharmacist-led seminar signifi-
cantly improves participants’ perceived medical proficien-
cy in providing care for patients who are transgender for
all key concepts discussed. Based on responses to the
preeducation scale, results point toward a gap in
education across students, trainees, and current health
care–associated workers regarding care of patients who
are transgender. The developed THEES showed good
internal consistency and face validity for assessing the
effectiveness of the given presentation. Thus, education
sessions of similar duration that follow the items assessed
by the THEES may be directly applicable to a variety of
health care–associated workers and trainees and may also
improve confidence level for providing care to patients
who are transgender in a similar fashion as this
presentation was shown to achieve.
One limitation to this study is that a large majority of
participants have a background in pharmacy. Future studies
utilizing the THEES should continue to include diverse
groups of healthcare professionals and students. A focus on
medication therapy, as noted by the magnitude of
improvement in item 4, may limit a nonpharmacist’s ability
to deliver the given presentation in this study. However, this
was only one aspect of the THEES, and differing groups of
clinical staff and trainees may not require in-depth
pharmaceutical review. Another limitation is the lack of
clinical outcomes data before and after education of health
care personnel, which could be studied in the future. Last,
future versions of the THEES will be best served by utilizing
the most contemporary language available to be more
gender-affirming and inclusive.
Conclusion
Current health profession education systems have recent-
ly improved with respect to the topic of providing health
FIGURE: Summed scale responses before and after education (*P , .001)
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care for patients who are transgender; however, deficits in
education continue to be present and have led to current
providers lacking in self-perceived proficiency and confi-
dence in caring for patients who are transgender.
Pharmacists in the clinical setting often have opportuni-
ties to deliver formal education sessions, and the reported
results demonstrate that a pharmacist-driven education
session that follows the items laid out in the THEES can
significantly help bridge the transgender education gap.
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